MagForce AG
MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of brain tumors; NanoPlan, a software that supports the attending physician in preparing the ideal treatment …
Medical - Instruments & Supplies
DE, Berlin [HQ]
MF6.DE/Financial Reporting
Income Statements
Profit & Loss · 13 Statements · From 2021 to 2009Configuration
In Million EUR. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - - | - - | - - | - - | - - | - - | 2.00 | - - | - - | - - | - - | - - | - - | |
|
EPS
|
-1.08 | -1.90 | -2.08 | -1.08 | -0.07 | -0.04 | -0.06 | -0.28 | -0.28 | 0.16 | -0.32 | 0.50 | -353.29 | |
| Diluted in mil. | -1.08 | -1.90 | -2.08 | -1.08 | -0.07 | -0.04 | -0.06 | -0.28 | -0.28 | 0.16 | -0.32 | 0.50 | -353.29 | |
|
Profit
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Gross Margin | - - | - - | -707.37 | - - | - - | - - | -14.87 | -21.24 | 4.67 | -577.60 | 106.39 | 69.98 | -89.95 | |
| Pre Tax | -4.00 | -7.00 | -8.00 | -5.00 | -1.00 | -1.00 | -1.00 | -7.00 | -7.00 | 4.00 | -8.00 | 14.00 | -10.00 | |
| Profit Margin | - - | - - | -20,941.32 | - - | - - | - - | -60.04 | -1,526.08 | -1,042.28 | 6,488.11 | -1,039.23 | 2,374.53 | -3,003.67 | |
| ETR | -0.13 | 1.10 | -0.03 | -0.02 | -0.07 | -0.12 | -0.01 | -0.01 | -0.02 | 0.04 | -0.02 | 0.02 | -0.02 | |
| Net | -4.00 | -7.00 | -8.00 | -5.00 | -1.00 | -1.00 | -1.00 | -7.00 | -7.00 | 4.00 | -8.00 | 14.00 | -10.00 | |
| Profit Margin | - - | - - | -20,946.92 | - - | - - | - - | -60.05 | -1,526.31 | -1,042.45 | 6,485.20 | -1,039.44 | 2,374.12 | -3,004.20 | |
| EBITDA | -3.00 | -6.00 | -7.00 | -4.00 | -1.00 | - - | - - | -5.00 | -5.00 | 7.00 | -5.00 | 19.00 | -5.00 | |
| EBITDA Margin | - - | - - | -17,857.87 | - - | - - | - - | -38.02 | -1,066.53 | -832.50 | 11,394.83 | -616.42 | 3,174.03 | -1,599.09 | |
| Operating Income | -3.00 | -6.00 | -7.00 | -4.00 | -1.00 | - - | -1.00 | -5.00 | -7.00 | 6.00 | -5.00 | 18.00 | -6.00 | |
| Operating Margin | - - | - - | -18,516.02 | - - | - - | - - | -72.82 | -1,257.79 | -1,034.84 | 10,161.22 | -685.74 | 2,997.64 | -1,913.88 | |
| Interest Income | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Loss | -3.00 | -6.00 | -6.00 | -4.00 | -1.00 | - - | -4.00 | -7.00 | -7.00 | -6.00 | -6.00 | -18.00 | -6.00 | |
| Cost of Revenue | - - | - - | - - | - - | - - | - - | -2.00 | - - | - - | - - | - - | - - | - - | |
|
Operating Expenses
|
-2.00 | -6.00 | -6.00 | -4.00 | -1.00 | - - | -1.00 | -6.00 | -6.00 | -7.00 | -6.00 | -18.00 | -5.00 | |
| R&D | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| G&A | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| SG&A | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Interest Expenses | - - | - - | - - | -1.00 | - - | - - | - - | - - | - - | -1.00 | -1.00 | -3.00 | -2.00 | |
| Other Expenses | - - | - - | - - | -1.00 | - - | - - | - - | -1.00 | - - | -2.00 | -2.00 | -3.00 | -3.00 | |
|
WA Shares Outstanding
|
3.00 | 3.00 | 4.00 | 5.00 | 23.00 | 25.00 | 25.00 | 25.00 | 26.00 | 26.00 | 27.00 | 29.00 | - - | |
| Diluted | 3.00 | 3.00 | 4.00 | 5.00 | 23.00 | 25.00 | 25.00 | 25.00 | 26.00 | 26.00 | 27.00 | 29.00 | - - |